INDIANAPOLIS — An Indiana University School of Medicine researcher is working with the Mayo Clinic on a study looking at blood biomarkers and Alzheimer’s disease.
Dr. Jeffrey Dage's previous studies have demonstrated that blood levels of phosphorylated tau (P-tau) are indicators of the development of Alzheimer’s disease pathology in the brain.
READ: Study from Dr. Dage and others
Blood-based biomarkers are the goal in screening for and diagnosing Alzheimer’s disease in the population because they are less costly and invasive than imaging and a lumbar puncture, Dage and Dr. Michelle Mielke with the Mayo Clinic said.
The IU School of Medicine says there are multiple ways for Hoosiers to get involved in the research, including donating blood to the Indiana Biobank or by completing a participant referral form.
Additionally, some Indiana patients will receive new screenings for early detection of Alzheimer’s disease thanks to a pilot program.
The program provides a digital cognitive assessment tool to screen patients for Alzheimer’s and electronically check brain function. Currently, those screenings are not part of normal primary care visits.
The Core Cognitive Evaluation is completely iPad-based and combines a digital assessment with a lifestyle-based patient questionnaire to generate actionable insights for both providers and patients.
-
Landmark gift creates Huron Fund at Hendricks County Community Foundation
The Hendricks County Community Foundation has received its largest donation in its 30-year history. The $1.74 million gift establishes the Huron Family Fund.
Tuskegee Airmen honored at Indianapolis International Airport
The Indianapolis International Airport recognized National Tuskegee Airmen Day during a ceremony honoring 44 members with Hoosier ties.
Arizona Wildcats and Purdue Boilermakers play in Elite 8
The teams play Saturday for the first time this season. Arizona is 19-2 against the Big 12, and Purdue is 17-7 against the Big Ten.
Victim's family reacts to guilty verdict, remember loved one
